If You Stop Taking Testosterone Will Your Period Come Back?

For most people, menstruation resumes after stopping testosterone therapy, though the timeline varies. Research on transmasculine individuals who paused or discontinued testosterone consistently reports the return of menses, and the medical literature now documents dozens of pregnancies carried by people who previously used testosterone, confirming that the reproductive system can reactivate. How quickly your period comes back, what the first cycles feel like, and what factors speed up or slow down the process are less straightforward, and the answers depend on variables like how long you were on testosterone, your delivery method, and your underlying health.

How Testosterone Suppresses Menstruation

Testosterone therapy works to stop periods by disrupting the hormonal feedback loop between the brain and the ovaries. Exogenous testosterone suppresses signals from the hypothalamus and pituitary gland, which in turn reduces the production of the hormones that trigger ovulation and the buildup and shedding of the uterine lining. This is the same basic mechanism that causes sperm production to drop in cisgender men using testosterone or anabolic steroids: the body’s central hormone-regulation system detects high androgen levels and dials back its own reproductive signaling.¹

For many people starting testosterone, periods stop within the first few months. But suppression is not always complete or immediate. A study tracking transmasculine individuals found that new users of testosterone could still experience ovulatory events during the first four weeks, though by weeks four to eight, markers of ovulation were no longer detectable.² And a substantial minority of people report bleeding that persists well past the six-month mark, which brings us to an important point: the suppression testosterone provides is strong but not absolute.

Persistent Bleeding on Testosterone Is More Common Than Many Expect

About one in five transmasculine individuals on testosterone report persistent menstruation more than six months after starting therapy. A study of 382 participants found that roughly 23% experienced ongoing bleeding past that threshold.³ This matters for the question of period return after stopping because it tells us something about how variable the hormonal suppression is in the first place. If your body never fully stopped cycling while on testosterone, the return of a recognizable period after discontinuation may be quicker.

The delivery method made a significant difference. People using testosterone gels or creams had dramatically higher odds of persistent menstruation compared to those on injections. Body composition also played a role: individuals with a BMI of 30 or above were about half as likely to report persistent bleeding.³ Interestingly, whether your periods were regular before starting testosterone had no association with whether bleeding persisted during therapy.

What Happens to the Uterus and Ovaries During Testosterone Use

Testosterone thins the uterine lining. Transvaginal ultrasound measurements of transmasculine individuals after at least a year of testosterone showed a median endometrial thickness of about 3.9 mm, compared with roughly 4.9 mm in cisgender controls measured during the early follicular phase of the menstrual cycle.⁴ The lining is not destroyed, though. Biopsies from people on testosterone have shown a roughly even split between atrophic (inactive) and proliferative (active) endometrial tissue, suggesting that the uterus retains the capacity to rebuild its lining once the hormonal signal changes.

On the ovarian side, the picture is generally reassuring for people concerned about long-term fertility. One prospective study tracked ovarian reserve markers over 12 months of testosterone therapy. In individuals without a prior history of polycystic ovary syndrome (PCOS), there was no meaningful decline in anti-Müllerian hormone (AMH) levels or antral follicle count, both standard indicators of remaining egg supply.⁵ People with a PCOS history did see a decline in AMH, though PCOS is associated with elevated AMH levels to begin with, so some decrease may represent a move toward a more typical range rather than a genuine loss of reproductive potential.

Timeline for Menstrual Return After Stopping

There is no single clean number for how long it takes. The available evidence consistently reports that menses return, but individual timelines range widely. Some people see bleeding within weeks of their last dose. Others wait several months. The research community has not yet produced a large prospective study that follows hundreds of people through discontinuation and tracks exactly when the first period appears, so most of what clinicians relay comes from case series and smaller cohort studies.

A comprehensive review of reproductive capacity after gender-affirming testosterone therapy noted that “with pauses in testosterone for reproductive purposes, studies generally report the return of menses, although the time course for resumption may vary.”⁴ That phrasing, deliberately open-ended, reflects the reality that the evidence base is still growing. Most clinicians who work with transmasculine patients report that the majority of their patients see a return of menstruation within one to six months after stopping, but published controlled data pinning down the median wait time remain sparse.

Factors that likely influence the timeline include how long you were on testosterone, your age, and whether ovarian function was fully suppressed during treatment. If you were among the roughly one in five whose bleeding never fully stopped, the return may be faster simply because your hypothalamic-pituitary-ovarian axis never shut down completely.

Fertility After Testosterone

The return of a period is one thing; the return of ovulation and actual fertility is another. The good news is that the evidence so far suggests testosterone therapy does not permanently eliminate the ability to conceive. Researchers have identified about 99 reported pregnancies carried by someone who was previously on testosterone, or carried using eggs from someone who had previously used testosterone, with roughly 69 live births documented from those pregnancies.⁴

That said, the number 99 is drawn from published case reports and series, which means it represents confirmed and written-up pregnancies rather than the full scope of what has happened. The actual number of pregnancies after testosterone use is almost certainly higher. What the data do confirm is proof of concept: ovarian function can recover sufficiently for conception, even after years of testosterone therapy.

Ovulation tracking during active testosterone use has shown that ongoing ovulatory events are rare but not zero. In one study of individuals continuing testosterone, a single confirmed ovulation was observed across 61 combined months of use, though several other cycles showed hormonal patterns suggestive of attempted but dysfunctional ovulation.² This underscores two points: testosterone is not a reliable contraceptive while you are on it, and ovarian activity, even if suppressed, rarely vanishes entirely.

Does Duration of Testosterone Use Matter?

This is one of the most common follow-up questions, and the honest answer is that we do not have definitive proof that longer use permanently delays or prevents menstrual return. The ovarian reserve data are somewhat encouraging. In people without PCOS, AMH levels and follicle counts held steady over at least 12 months of therapy.⁵ But 12 months is a relatively short window, and many people use testosterone for five, ten, or more years. Whether ovarian reserve remains intact after a decade of use is a question the current literature cannot fully answer.

For context, the broader endocrine literature on exogenous hormone use and reproductive recovery provides some indirect parallels. In cisgender men who use testosterone replacement therapy or anabolic steroids, spontaneous recovery of sperm production typically occurs if given enough time after cessation, though recovery is slower and less predictable with longer use.¹ The analogy is imperfect, because the ovarian and testicular systems differ in important ways, but the general principle holds: the hypothalamic-pituitary-gonadal axis tends to bounce back once the exogenous hormone is removed, even if the timeline varies.

The Role of PCOS

Polycystic ovary syndrome adds a layer of complexity. Many transmasculine individuals had irregular periods before starting testosterone, sometimes due to undiagnosed PCOS, and the interplay between pre-existing PCOS and exogenous testosterone is still being untangled. The clearest finding so far is that testosterone use appears to lower AMH levels specifically in people with a PCOS history, while leaving AMH unchanged in those without PCOS. In one study, the AMH decline in the PCOS subgroup was strong enough to drive an apparent decline for the entire cohort, even though individuals without PCOS showed no change at all.⁵

What this means in practical terms: if you had PCOS before starting testosterone, your hormonal milieu after stopping may look different from someone who did not. PCOS-related irregular cycles could return alongside the normal period, making it harder to distinguish between “my body is recovering from testosterone suppression” and “my body is returning to its pre-testosterone baseline, which was already irregular.” Working with an endocrinologist or gynecologist familiar with both PCOS and gender-affirming care can help sort out what is happening.

What to Expect Physically When You Stop

The return of menstruation is the most visible change, but stopping testosterone triggers a broader hormonal shift. As exogenous testosterone levels drop, the pituitary gland begins ramping up its own signaling again, estrogen levels gradually rise, and the body moves back toward its pre-testosterone hormonal balance. This transition can feel physically uncomfortable. Some people report hot flashes, mood swings, fatigue, and changes in body composition during the weeks and months after stopping. These are not well-documented in large studies specific to transmasculine individuals, but they align with what is known about hormonal fluctuations in general.

Lipid and lipoprotein profiles also shift. Testosterone therapy tends to alter cholesterol levels, but research on individuals who stopped androgen therapy for six to twelve months found no significant difference in lipid profiles compared to their pre-treatment baselines.⁶ In other words, whatever testosterone did to your cholesterol while you were on it appears to be reversible once you stop.

Bone density is worth considering, particularly for people who stop testosterone without replacing it with estrogen. Testosterone supports bone mineral density, and studies in older cisgender men with low testosterone have shown meaningful gains in spine bone density and estimated bone strength during treatment.⁷ Discontinuing testosterone means losing that androgenic bone support. If the body’s own estrogen production resumes quickly, estrogen can take over the bone-protective role. But if there is a prolonged gap where neither hormone is circulating at adequate levels, bone health could be affected. This is a conversation worth having with your provider, especially if you plan to stay off hormones indefinitely.

Psychological and Practical Challenges of Stopping

Stopping testosterone is not just a biological event. For some people, it involves navigating complicated emotional and social terrain. A qualitative study of individuals who discontinued or reversed prior gender-affirming treatments found that participants experienced the process as both physically and psychologically challenging. Health care during detransition was often perceived as suboptimal, in part due to stigma and in part because clinicians simply lacked information about what to expect.⁸

People stop testosterone for many different reasons. Some are detransitioning. Others are pausing temporarily for fertility purposes. Still others discontinue due to side effects, access issues, or shifting treatment goals. The experience of menstrual return lands differently depending on why you stopped. For someone pausing to pursue pregnancy, the return of a period may feel like a welcome sign that their body is cooperating. For someone detransitioning, or for a nonbinary person navigating a complicated relationship with their body, the same event can carry significant distress. Whatever your reason, finding a clinician who can discuss both the endocrine and emotional dimensions without judgment is valuable and, according to the research, harder to find than it should be.

Can You Prevent Periods From Returning Without Testosterone?

If you are stopping testosterone for medical or personal reasons but do not want menstruation to resume, there are options. Hormonal IUDs that release progestin locally can thin the uterine lining and suppress or lighten periods without systemic hormonal effects that would conflict with many people’s goals. Continuous-use progestin-only pills or injections are another option. Endometrial ablation, a procedure that destroys the uterine lining, can reduce or stop bleeding more permanently, though it is not recommended for anyone who might want to carry a pregnancy in the future. Hysterectomy, of course, is definitive.

The right choice depends on your broader health picture and your plans. If you are pausing testosterone temporarily with the intention of restarting, a short-acting hormonal method may bridge the gap. If you are stopping permanently and want menstrual suppression without testosterone, a longer-acting approach may make more sense. These decisions are best made with a provider who understands your full history.

What Researchers Still Do Not Know

The evidence base on reproductive recovery after testosterone is growing quickly, but significant gaps remain. Most studies to date have relatively small sample sizes and short follow-up periods. There is very little data on what happens to ovarian reserve after five or ten years of continuous testosterone use. The interaction between testosterone duration, age at discontinuation, and time to menstrual return has not been modeled in a large cohort. And while roughly 99 pregnancies after testosterone have been documented in the medical literature, detailed outcome data, including miscarriage rates, gestational complications, and neonatal health, are still sparse.⁴

The systematic review literature also acknowledges that while testosterone is generally effective at suppressing menstruation, breakthrough bleeding and ovulatory activity occur in a “substantial proportion” of individuals, and the mechanisms behind this variability are not fully understood.⁹ Why some people’s ovaries stay more active under testosterone than others is an open question that probably involves individual variation in receptor sensitivity, testosterone metabolism, and the completeness of hypothalamic suppression. Until larger and longer studies fill in these blanks, clinicians and patients are working with a picture that is encouraging but incomplete.

1
PubMed Central. Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use
2
PubMed Central. The effect of testosterone on ovulatory function in transmasculine individuals
3
Taylor & Francis Online (International Journal of Transgender Health). Persistent menstruation in transgender people using testosterone gender-affirming hormone therapy
4
Human Reproduction. Reproductive capacity after gender-affirming testosterone therapy
5
Human Reproduction. Functional ovarian reserve in transgender men receiving testosterone therapy: evidence for preserved anti-Müllerian hormone and antral follicle count under prolonged treatment
6
Elsevier / Maturitas. The impact of long-term testosterone replacement therapy on lipid and lipoprotein profiles in women
7
PubMed Central. Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone
8
JAMA Network Open. Health Care Experiences of Patients Discontinuing or Reversing Prior Gender-Affirming Treatments
9
PubMed Central. Gynecologic function and dysfunction in transmasculine and gender-diverse individuals using testosterone therapy: a systematic review